SCHEMBL23664786

SCHEMBL23664786

c1ccc(N(c2ccc3c(c2)sc2ccccc23)c2cc(N(c3ccccc3)c3ccc4c(c3)sc3ccccc34)c3sc4ccc(-c5ccc6sc7ccccc7c6c5)cc4c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
RAB9A P51151 2/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LIMK1 P53667 2/20 0.34
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
GPR3 P46089 1/20 0.33
ALOX5 P09917 1/20 0.32
PTGIR P43119 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
CYP1A2 P05177 1/20 0.31
ATM Q13315 1/20 0.31
KDM4E B2RXH2 1/20 0.31
PTPN7 P35236 1/20 0.30
DUSP3 P51452 1/20 0.30
PTPN12 Q05209 1/20 0.30
PTPN22 Q9Y2R2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23871146 0.99 LIMK1 (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23664784 0.96 TNKS (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21342290 0.95 TNKS (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21936449 0.95 MAPT (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21936528 0.95 MAPT (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23871171 0.95 MAPT (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23871204 0.95 MAPT (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23871134 0.95 MAPT (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23664777 0.94 TNKS (0.37) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23664775 0.93 LIMK1 (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11133471-B2 Compound for organic electronic element, organic electronic element using same and electronic device therefor DUK SAN NEOLUX CO., LTD 2021-09-28 US disclosed
US-20210226131-A1 Compound For Organic Electronic Element, Organic Electronic Element Using Same And Electronic Device Therefor DUK SAN NEOLUX CO., LTD (KR) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11133471-B2 Compound for organic electronic element, organic electronic element using same and electronic device therefor OR51E2, SLC39A11, WEE1 MAPT 2688/4885ALDH1A1 43/4885RAB9A 3424/4885
US-20210226131-A1 Compound For Organic Electronic Element, Organic Electronic Element Using Same And Electronic Device Therefor OR51E2, SLC39A11, WEE1 MAPT 2688/4885ALDH1A1 43/4885RAB9A 3424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.